No Prescription |
 |
 | ||
|
Aropax Paxil |
|
| ||
No Prescription » Prescription Drugs 2 » Aropax Paxil AROPAX belongs to a group of medicines called selective serotonin reuptake inhibitor (SSRI) antidepressants. They are thought to work by their action on brain chemicals called amines which are involved in controlling mood.Depression is longer lasting or more severe than the 'low moods' that everyone has from time to time. It is thought to be caused by a chemical imbalance in parts of the brain. This imbalance affects your whole body and can cause emotional and physical symptoms. You may feel low in spirit lose interest in usual activities be unable to enjoy life have poor appetite or over eat have disturbed sleep often waking up early low energy and feel guilty over nothing. AROPAX corrects the chemical imbalance and so helps relieve the symptoms of depression.AROPAX may also be used to treat irrational fears general anxiety and obsessive behaviour. These can also be due to chemical imbalances in parts of the brain.AROPAX may also be used to treat the symptoms of panic attacks. When taken regularly it will help prevent the attacks.AROPAX may also be used to treat patients who may avoid and/or are fearful of social situations (general and social anxiety).AROPAX may also be used to treat patients who suffer from anxiety caused by re-experiencing an extremely traumatic event (Post Traumatic Stress Disorder)Your doctor may decide that you should continue to use AROPAX for some time even when you have overcome your problem. This should prevent the problem from returning. Buy Aropax Paxil and other Prescription Drugs 2 products online at Medstore. 5088
About Aropax Paxil: Product Type: Prescription Drugs 2 Aropax ( Paxil Generic Paroxetine ) Aropax (Paxil Generic Paroxetine) Paxil Generic Paroxetine 20mg 30 Tablets Paxil Generic Paroxetine Aropax
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
